Period Ending | Mar 30, 2013 |
---|
Total Revenue
|
4,329,000
| Cost of Revenue | 1,153,000 | |
Gross Profit
|
3,176,000
| |
|
Operating Expenses |
|
Research Development | 634,000 |
|
Selling General and Administrative | 1,237,000 |
|
Non Recurring |
-
|
|
Others |
-
|
|
|
|
Total Operating Expenses |
-
| | |
Operating Income or Loss
|
1,305,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
|
Earnings Before Interest And Taxes | 1,239,000 |
|
Interest Expense |
-
|
|
Income Before Tax | 1,239,000 |
|
Income Tax Expense | 271,000 |
|
Minority Interest |
-
|
|
|
|
Net Income From Continuing Ops | 968,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
|
Extraordinary Items |
-
|
|
Effect Of Accounting Changes |
-
|
|
Other Items |
-
| | |
Net Income
|
968,000
| Preferred Stock And Other Adjustments |
-
| |
Net Income Applicable To Common Shares
|
968,000
|
|